Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global RNA Based Therapeutics Market Size study, by Technology (Enabling Technologies, Enabled Technologies), by Application (Cardiovascular, Kidney Diseases, Oncology, Infectious Diseases, Metabolic disorders, Others), by End-User (Research, Therapeutics, Diagnosis) and Regional Forecasts 2020-2027

  • BIZ4192976
  • 200 Pages
  • February 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global RNA Based Therapeutics Market is valued at approximately USD 0.93 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 28.4% over the forecast period 2020-2027. Healthcare sector have undertaken their attention to bring constancy to the RNA molecules in the body with limited bioavailability. For this, RNA therapeutics is being developed and when combined with protein/lipid nanoparticles deliver better stability. Despite being in a clinical research phase, the RNA therapeutics is being extensively discovered with a primary target to find a cure for unmet medical circumstances and rare diseases. Since, this field is significantly based on research, the advancements in technology assist in expanding the market and its geographical area. Advancement of promising technologies, such as antisense technology, RNAi interference technology, and smart technology that provides optimistic future growth prospect to the market in the forthcoming period. Furthermore, the rise in prevalence of infectious diseases, along with the more intense product focus against technology are the few factors responsible for the high CAGR of the market during the forecast period. According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, there were 1.7 million people were newly influenced by HIV, as compared to a 2.8 million population of adults in 1998. Similarly, in August 2018, BioNTech AG has entered into a research and development (R&D) collaboration with Pfizer to develop Messenger RNA (mRNA) -based influenza vaccines. These exciting strategic collaborations and partnerships lead to pioneering developments in the RNA-based therapeutics field. This, in turn, is expected to strengthen the market growth all over the world. However, the high cost of research and risk of failure, coupled with complications in drug delivery are the few major factors limiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global RNA Based Therapeutics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rapid adoption of new technologies and therapeutic for drug delivery, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of patients with chronic diseases, such as cancer and cardiovascular diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the RNA Based Therapeutics market across the Asia-Pacific region.

Major market player included in this report are:

Quark Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

Dicerna Pharmaceuticals, Inc.

Tekmira Pharmaceuticals Corp.

Benitec Biopharma Limited

Cenix BioScience GmbH

Genzyme Corporation

Silence Therapeutics PLC

Sirnaomics, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:

Enabling technologies (such as microarrays, labeling, purification, and others)

Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)

By Application:

Cardiovascular

Kidney Diseases

Oncology

Infectious diseases

Metabolic disorders

Others

By End-User:

Research

Therapeutics

Diagnosis

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018

Base year – 2019

Forecast period – 2020 to 2027

Target Audience of the Global RNA Based Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)

1.2.1. RNA Based Therapeutics Market, by Region, 2018-2027 (USD Billion)

1.2.2. RNA Based Therapeutics Market, by Technology, 2018-2027 (USD Billion)

1.2.3. RNA Based Therapeutics Market, by Application, 2018-2027 (USD Billion)

1.2.4. RNA Based Therapeutics Market, by End-User, 2018-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global RNA Based Therapeutics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global RNA Based Therapeutics Market Dynamics

3.1. RNA Based Therapeutics Market Impact Analysis (2018-2027)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global RNA Based Therapeutics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global RNA Based Therapeutics Market, by Technology

5.1. Market Snapshot

5.2. Global RNA Based Therapeutics Market by Technology, Performance - Potential Analysis

5.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)

5.4. RNA Based Therapeutics Market, Sub Segment Analysis

5.4.1. Enabling technologies (such as microarrays, labeling, purification, and others)

5.4.2. Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)

Chapter 6. Global RNA Based Therapeutics Market, by Application

6.1. Market Snapshot

6.2. Global RNA Based Therapeutics Market by Application, Performance - Potential Analysis

6.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)

6.4. RNA Based Therapeutics Market, Sub Segment Analysis

6.4.1. Cardiovascular

6.4.2. Kidney Diseases

6.4.3. Oncology

6.4.4. Infectious diseases

6.4.5. Metabolic disorders

6.4.6. Others

Chapter 7. Global RNA Based Therapeutics Market, by End-User

7.1. Market Snapshot

7.2. Global RNA Based Therapeutics Market by End-User - Potential Analysis

7.3. Global RNA Based Therapeutics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)

7.4. RNA Based Therapeutics Market, Sub Segment Analysis

7.4.1. Research

7.4.2. Therapeutics

7.4.3. Diagnosis

Chapter 8. Global RNA Based Therapeutics Market, Regional Analysis

8.1. RNA Based Therapeutics Market, Regional Market Snapshot

8.2. North America RNA Based Therapeutics Market

8.2.1. U.S. RNA Based Therapeutics Market

8.2.1.1. Technology breakdown estimates & forecasts, 2017-2027

8.2.1.2. Application breakdown estimates & forecasts, 2017-2027

8.2.1.3. End-User breakdown estimates & forecasts, 2017-2027

8.2.2. Canada RNA Based Therapeutics Market

8.3. Europe RNA Based Therapeutics Market Snapshot

8.3.1. U.K. RNA Based Therapeutics Market

8.3.2. Germany RNA Based Therapeutics Market

8.3.3. France RNA Based Therapeutics Market

8.3.4. Spain RNA Based Therapeutics Market

8.3.5. Italy RNA Based Therapeutics Market

8.3.6. Rest of Europe RNA Based Therapeutics Market

8.4. Asia-Pacific RNA Based Therapeutics Market Snapshot

8.4.1. China RNA Based Therapeutics Market

8.4.2. India RNA Based Therapeutics Market

8.4.3. Japan RNA Based Therapeutics Market

8.4.4. Australia RNA Based Therapeutics Market

8.4.5. South Korea RNA Based Therapeutics Market

8.4.6. Rest of Asia Pacific RNA Based Therapeutics Market

8.5. Latin America RNA Based Therapeutics Market Snapshot

8.5.1. Brazil RNA Based Therapeutics Market

8.5.2. Mexico RNA Based Therapeutics Market

8.6. Rest of The World RNA Based Therapeutics Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Quark Pharmaceuticals, Inc.

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Alnylam Pharmaceuticals, Inc.

9.2.3. Dicerna Pharmaceuticals, Inc.

9.2.4. Tekmira Pharmaceuticals Corp.

9.2.5. Benitec Biopharma Limited

9.2.6. Cenix BioScience GmbH

9.2.7. Genzyme Corporation

9.2.8. Silence Therapeutics PLC

9.2.9. Sirnaomics, Inc.

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. Global RNA Based Therapeutics market, report scope

TABLE 2. Global RNA Based Therapeutics market estimates & forecasts by region 2017-2027 (USD Billion)

TABLE 3. Global RNA Based Therapeutics market estimates & forecasts by Technology 2017-2027 (USD Billion)

TABLE 4. Global RNA Based Therapeutics market estimates & forecasts by Application 2017-2027 (USD Billion)

TABLE 5. Global RNA Based Therapeutics market estimates & forecasts by End-User 2017-2027 (USD Billion)

TABLE 6. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 7. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 8. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 9. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 10. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 11. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 12. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 13. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 14. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 15. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 16. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 17. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 18. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 19. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 20. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 21. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)

TABLE 22. U.S. RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 23. U.S. RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 24. U.S. RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 25. Canada RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 26. Canada RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 27. Canada RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 28. UK RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 29. UK RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 30. UK RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 31. Germany RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 32. Germany RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 33. Germany RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 34. France RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 35. France RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 36. France RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 37. Spain RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 38. Spain RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 39. Spain RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 40. Italy RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 41. Italy RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 42. Italy RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 43. ROE RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 44. ROE RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 45. ROE RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 46. China RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 47. China RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 48. China RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 49. India RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 50. India RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 51. India RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 52. Japan RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 53. Japan RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 54. Japan RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 55. Australia RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 56. Australia RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 57. Australia RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 58. South Korea RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 59. South Korea RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 60. South Korea RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 61. ROPAC RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 62. ROPAC RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 63. ROPAC RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 64. Brazil RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 65. Brazil RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 66. Brazil RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 67. Mexico RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 68. Mexico RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 69. Mexico RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 70. ROLA RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 71. ROLA RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 72. ROLA RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 73. ROW RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)

TABLE 74. ROW RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 75. ROW RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)

TABLE 76. List of secondary sources, used in the study of global RNA Based Therapeutics market

TABLE 77. List of primary sources, used in the study of global RNA Based Therapeutics market

TABLE 78. Years considered for the study

TABLE 79. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research